Information Provided By: 
Fly News Breaks for June 26, 2017
ESRX, DPLO
Jun 26, 2017 | 15:35 EDT
Cowen analyst Charles Rhyee noted his prior observation following meetings with Express Scripts (ESRX) that the company plans to be more aggressive with DIR fees. However, he estimates a maximum potential downside of $1.36 per Diplomat Pharmacy (DPLO) share in such a scenario, or a bit over 7% of Friday's closing price, making today's pullback an overreaction in his view. He keeps a Market Perform rating and $17 price target on Diplomat shares, which remain down about 8.5% at $16.82 but are well off their earlier lows.
News For DPLO;ESRX From the Last 2 Days
There are no results for your query DPLO;ESRX
